Recent And Upcoming FDA Advisory Committee Meetings

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.

Topics	Advisory Committee	Date	Details
Gilead's Descovy (emtricitabine/tenofovir alafenamide) for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 infection among individuals who are HIV-negative and at risk for HIV	Antimicrobial Drugs	August 7	Meeting notice (Also see "Gilead's Descovy HIV Prevention Indication Should Exclude Women, US FDA Advisory Cmte. Says" - Pink Sheet, 7 Aug, 2019.)
Aimmune Therapeutics' peanut [Arachis hypogaea] allergen powder to reduce the risk of anaphylaxis after accidental exposure to peanut in patients ages 4-17 years with a confirmed peanut allergy diagnosis	Allergenic Products	Sept. 13	Meeting notice